These preclinical studies show that inhibition of several inflammatory targets, through genetic, viral, and pharmacological modulation, decreases ethanol drinking in different animal models of AUD. Overall, the findings suggest that alcohol-induced neuroimmune activation plays a central role in the behavioral actions of alcohol.